ANTIBODY RESOPNSES TO THE EPSTEIN-BARR VIRUS AND SYTOMEGALOVIRUSES AFTER TRANSFUSION

Jia Qingliang et al Deparment of Epidemiology

doi:10.13406/j.cnki.cyxb.1992.01.004

您当前的位置：

首页 >

文章列表页 >

ANTIBODY RESOPNSES TO THE EPSTEIN-BARR VIRUS AND SYTOMEGALOVIRUSES AFTER TRANSFUSION

更新时间：2024-01-17

- ANTIBODY RESOPNSES TO THE EPSTEIN-BARR VIRUS AND SYTOMEGALOVIRUSES AFTER TRANSFUSION
- Journal of Chongqing Medical University Issue 1, Pages: 15-18(1992)
- 作者机构：
  
  1. 重庆医科大学流行病学教研室
  2. 重庆医科大学第一医院中心实验室
  3. 重庆医科大学流行病学教研室重庆医科大学第一医院中心实验室
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.1992.01.004
  CLC：
- Published：1992，
扫描看全文
[1]贾庆良,马贵成,欧阳真纯.输血后HBV EBV CMV感染的系列研究——Ⅱ输血后EBV CMV抗体反应的研究[J].重庆医科大学学报,1992(01):15-18.

Jia Qingliang et al Deparment of Epidemiology. ANTIBODY RESOPNSES TO THE EPSTEIN-BARR VIRUS AND SYTOMEGALOVIRUSES AFTER TRANSFUSION. [J]. Journal of Chongqing Medical University (1):15-18(1992)
[1]贾庆良,马贵成,欧阳真纯.输血后HBV EBV CMV感染的系列研究——Ⅱ输血后EBV CMV抗体反应的研究[J].重庆医科大学学报,1992(01):15-18. DOI： 10.13406/j.cnki.cyxb.1992.01.004.

Jia Qingliang et al Deparment of Epidemiology. ANTIBODY RESOPNSES TO THE EPSTEIN-BARR VIRUS AND SYTOMEGALOVIRUSES AFTER TRANSFUSION. [J]. Journal of Chongqing Medical University (1):15-18(1992) DOI： 10.13406/j.cnki.cyxb.1992.01.004.

摘要

用酶联免疫法对受血者及健康对照者进行为期6个月EBV CMV抗体反应的血清学追踪调查

发现受血者、对照者EBV感染再活动率分别为31.86%和15.24%

相对危险度（RR）为2.09;CMV感染再活动率分别为33.33%和10.48%

RR为3.18

Abstract

A serological study of IgG and IgM to Epstein-barr virus(EBV) and cytomega-lovirus(CMV)by ELISA was made in blood recipients and healthly contorl persons with 6 months follow-up study . The results showed the EBV reactivation rate of blood recipients and contorl were 31.86% and 15.24%

respectively; the relative risk (RR) was 2.09. the CMV reactivation rate of blood recipients and contorl were 33.33% and 10.48%

respectively and the RR was 3.18

关键词

输血爱波斯坦—巴尔病毒巨细胞病毒再活动追踪调查

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

IMPROVEMENT OF THE PAPAIN TEST FORDETERMINATION OF BLOOD TRANSFUSIONCOMPATIBILITY AND ITS CLINICAL APPLICATION

Related Author

Wei Yanyong

et al

唐文淦

Related Institution

No data

⁰